Procter & Gamble Health Limited
PGHL.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$86.72B
Close$
Share Statistics
| Market cap | $86.72 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $250.00 (3.94%) |
| Earnings per Share | $196.94 |
| Beta | 0.2 |
| Outstanding Shares | 16,600,483 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 24.21 |
|---|---|
| PEG | 53.46 |
| Price to Sales | 6.03 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Procter & Gamble Health Limited
1,336 employees
CEO: Milind Vasant Thatte Procter & Gamble Health Limited is engaged in the development, manufacturing, and global distribution of pharmaceuticals and chemical products, with operations both within India and across international markets. Its product range include...